انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Suraj Mudichintala on investing in bioelectronic medicine companies with Action Potential Venture
Manage episode 359131309 series 2968631
Suraj Mudichintala is a Senior Associate at Action Potential Capital which is GSK's bioelectronic medicine venture fund.
Top 3 Takeaways:
- "Our fund is different in that we invest actually directly off of GSK's balance sheet. So we're what's called an evergreen fund where we don't actually have a fund size"
- "The way that I think about it is that a VC is really paid to allocate capital but really is really paid to think. You really have to think about what is the next space or the next technology that could disrupt a space? And because of that, it's a much you often have to take a much more longitudinal view. And it takes a lot of patience and tracking a space oftentimes for years"
- "When you reach out to a VC having a pitch, first of all, sending a non-confidential pitch deck is mandatory, I think. And that deck is essentially where we're making the first decision as to whether or not to do a call with you"
0:45 Do you want to introduce yourself better than I just did?
1:15 "Do you wanna talk about Action Potential, what it is, who it was formed by, and the investment thesis?"
2:30 Do you want to talk about the expansion of the AP investment thesis?
4:30 What does traditional Venture Capital look like and how is it different in that you are funded by GSK?
6:15 What do the positions within a VC firm look like?
7:45 How has it been for you going from Analyst to Associate?
8:45 What does your due diligence look like?
11:45 "A lot of VCs have a target size range, be it seed or angel or, maybe larger institutional stuff. But it sounds like you guys don't really have that?"
12:45 "How did you get into this space?"
14:45 "So how does consulting compare to the VC life?"
18:45 "What would you suggest is the best way to get your attention?"
24:00 What are some tips and tricks to reaching out to you?
27:00 What was the worst pitch deck you ever saw?
28:30 " Is there anything that we didn't talk about that you wanted to mention?"
248 حلقات
Suraj Mudichintala on investing in bioelectronic medicine companies with Action Potential Venture
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
Manage episode 359131309 series 2968631
Suraj Mudichintala is a Senior Associate at Action Potential Capital which is GSK's bioelectronic medicine venture fund.
Top 3 Takeaways:
- "Our fund is different in that we invest actually directly off of GSK's balance sheet. So we're what's called an evergreen fund where we don't actually have a fund size"
- "The way that I think about it is that a VC is really paid to allocate capital but really is really paid to think. You really have to think about what is the next space or the next technology that could disrupt a space? And because of that, it's a much you often have to take a much more longitudinal view. And it takes a lot of patience and tracking a space oftentimes for years"
- "When you reach out to a VC having a pitch, first of all, sending a non-confidential pitch deck is mandatory, I think. And that deck is essentially where we're making the first decision as to whether or not to do a call with you"
0:45 Do you want to introduce yourself better than I just did?
1:15 "Do you wanna talk about Action Potential, what it is, who it was formed by, and the investment thesis?"
2:30 Do you want to talk about the expansion of the AP investment thesis?
4:30 What does traditional Venture Capital look like and how is it different in that you are funded by GSK?
6:15 What do the positions within a VC firm look like?
7:45 How has it been for you going from Analyst to Associate?
8:45 What does your due diligence look like?
11:45 "A lot of VCs have a target size range, be it seed or angel or, maybe larger institutional stuff. But it sounds like you guys don't really have that?"
12:45 "How did you get into this space?"
14:45 "So how does consulting compare to the VC life?"
18:45 "What would you suggest is the best way to get your attention?"
24:00 What are some tips and tricks to reaching out to you?
27:00 What was the worst pitch deck you ever saw?
28:30 " Is there anything that we didn't talk about that you wanted to mention?"
248 حلقات
كل الحلقات
×
1 Expanding Horizons in Neuroprosthetics: A Conversation with Andreas Forsland 40:12

1 Exploring the Miami Project to Cure Paralysis with David McMillan 29:26

1 Exploring Contract Engineering in Neurotechnology with Javier Schandy and Nicolas Barabino 28:31

1 Stephen Ho: Exploring Neurotech in Cinema with the Neurratives Podcast 22:13

1 Eugene Daneshvar: Navigating Neurotech and Patents 34:50

1 Paul Le Floch: Pioneering Neural Implant Materials with Axoft 24:25

1 Christine Schmidt: Pioneering Regenerative Neural Tissue Engineering 38:26

1 Bioel 2024 Conference panel with Drs Jon Viventi, Tracy Cui, Ellis Meng, and Ivan Minev 1:09:46

1 Carles Garcia-Vitoria: Pioneering Pain Relief with Intrathecal Spinal Cord Stimulation with Spinally 23:33

1 Steve Goetz: Revolutionizing Mental Health Treatment as CTO of Motif Neurotech 54:15

1 Eric Glowacki on cutting edge neural implant fabrication 34:04

1 Gene Fridman on his freeform stimulator allowing for more neural stimulation possibilities 33:24

1 Kurt Haggestrom on Synchron's Stentrode and Synch Switch 19:55

1 Pawel Soluch on launching the Medtech Coaching program with me 26:11

1 Mounya Elhilali on her auditory processing selectivity research 17:35
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.